Breakfast on Postprandial Hyperglycemia
Launched by HOSPITAL DE CLINICAS CARACAS · Apr 7, 2015
Trial Information
Current as of August 26, 2025
Unknown status
Keywords
ClinConnect Summary
In type 2 diabetic individuals the omission of breakfast is associated with significant increase in HbA1C and all-day postprandial hyperglycemia even without overeating in the evening. In contrast, high-energy breakfast and low-energy dinner result in a significant reduction of all-day postprandial glycaemia Similarly, 3 months of high-energy breakfast led to a 5% reduction in HbA1C levels in type 2 diabetes participants Despite the growing evidence showing the beneficial effects of breakfast consumption on overall postprandial hyperglycemia and HbA1C levels, very little is known regarding ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI: 26-34 kg/m2.
- • HbA1c \> 7 %
- • T2D since \< 10 yrs,
- • . Only non treated or treated with oral antidiabetic drugs
- • Those treated with insulin or GLP-1 analogs will be excluded.
- Exclusion Criteria:
- • Type 1 diabetes
- • Serum creatinine level \> 1.5 mg/dl
- • Pulmonary disease, psychiatric, immunological, neoplastic diseases or severe diabetic complications,such as cardiovascular disease, cerebrovascular disease, proliferative diabetic retinopathy, gastroparesis or anemia (Hg \> 10g/dL) or underwent bariatric surgery.
- • Abnormal liver function tests
- • Participating in dietary program or using of weight-loss medications
- • History (within one year) of illicit drug abuse or alcoholism.
- • Use of psychotropic or anoretic medication during the month immediately prior to study onset
About Hospital De Clinicas Caracas
Hospital de Clínicas Caracas is a leading healthcare institution in Venezuela, renowned for its commitment to providing high-quality medical care and advancing clinical research. As a prominent sponsor of clinical trials, the hospital fosters innovative research initiatives aimed at enhancing patient outcomes and contributing to the global medical community. With a multidisciplinary team of experienced healthcare professionals and researchers, Hospital de Clínicas Caracas emphasizes ethical standards, patient safety, and scientific rigor in its clinical investigations, making it a pivotal player in the field of medical research in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Daniela Jakubowicz, MD
Principal Investigator
Hospital de Clinicas Caracas
Daniela Jakubowicz, MD
Principal Investigator
E. Wolfson Medical Center. Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials